Care Twentyone Corporation
Care Twentyone Corporation (2373.T) Stock Competitors & Peer Comparison
See (2373.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 2373.T | ¥437.00 | +0.46% | 5.9B | 15.35 | ¥28.47 | +3.89% |
| 6197.T | ¥1,116.00 | +0.00% | 101.6B | 23.47 | ¥47.54 | +1.97% |
| 6099.T | ¥738.00 | +0.41% | 44.6B | 16.12 | ¥45.79 | +1.62% |
| 6062.T | ¥1,349.00 | +1.73% | 44.1B | 13.33 | ¥101.23 | +3.70% |
| 7071.T | ¥426.00 | +1.67% | 41.5B | 11.35 | ¥37.53 | +0.94% |
| 2372.T | ¥2,790.00 | +0.00% | 33.8B | 131.60 | ¥21.20 | N/A |
| 2374.T | ¥1,212.00 | +0.00% | 29.9B | 0.00 | ¥413,067,936.00 | N/A |
| 9158.T | ¥984.00 | +5.02% | 28.8B | 16.62 | ¥59.22 | N/A |
| 194A.T | ¥1,600.00 | -0.25% | 12.1B | 16.99 | ¥94.15 | N/A |
| 9229.T | ¥249.00 | -0.40% | 8.1B | -2.98 | -¥83.66 | N/A |
Stock Comparison
2373.T vs 6197.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 6197.T has a market cap of 101.6B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 6197.T trades at ¥1,116.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 6197.T's P/E ratio is 23.47. In terms of profitability, 2373.T's ROE is +0.12%, compared to 6197.T's ROE of +0.18%. Regarding short-term risk, 2373.T is more volatile compared to 6197.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2373.T.Check 6197.T's competition here
2373.T vs 6099.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 6099.T has a market cap of 44.6B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 6099.T trades at ¥738.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 6099.T's P/E ratio is 16.12. In terms of profitability, 2373.T's ROE is +0.12%, compared to 6099.T's ROE of +0.21%. Regarding short-term risk, 2373.T is less volatile compared to 6099.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 6099.T's competition here
2373.T vs 6062.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 6062.T has a market cap of 44.1B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 6062.T trades at ¥1,349.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 6062.T's P/E ratio is 13.33. In terms of profitability, 2373.T's ROE is +0.12%, compared to 6062.T's ROE of +0.16%. Regarding short-term risk, 2373.T is less volatile compared to 6062.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 6062.T's competition here
2373.T vs 7071.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 7071.T has a market cap of 41.5B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 7071.T trades at ¥426.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 7071.T's P/E ratio is 11.35. In terms of profitability, 2373.T's ROE is +0.12%, compared to 7071.T's ROE of +0.09%. Regarding short-term risk, 2373.T is less volatile compared to 7071.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 7071.T's competition here
2373.T vs 2372.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 2372.T has a market cap of 33.8B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 2372.T trades at ¥2,790.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 2372.T's P/E ratio is 131.60. In terms of profitability, 2373.T's ROE is +0.12%, compared to 2372.T's ROE of +0.11%. Regarding short-term risk, 2373.T is more volatile compared to 2372.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2373.T.Check 2372.T's competition here
2373.T vs 2374.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 2374.T has a market cap of 29.9B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 2374.T trades at ¥1,212.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 2374.T's P/E ratio is 0.00. In terms of profitability, 2373.T's ROE is +0.12%, compared to 2374.T's ROE of +0.10%. Regarding short-term risk, 2373.T is more volatile compared to 2374.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2373.T.Check 2374.T's competition here
2373.T vs 9158.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 9158.T has a market cap of 28.8B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 9158.T trades at ¥984.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 9158.T's P/E ratio is 16.62. In terms of profitability, 2373.T's ROE is +0.12%, compared to 9158.T's ROE of +0.06%. Regarding short-term risk, 2373.T is less volatile compared to 9158.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 9158.T's competition here
2373.T vs 194A.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 194A.T has a market cap of 12.1B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 194A.T trades at ¥1,600.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 194A.T's P/E ratio is 16.99. In terms of profitability, 2373.T's ROE is +0.12%, compared to 194A.T's ROE of +0.26%. Regarding short-term risk, 2373.T is less volatile compared to 194A.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 194A.T's competition here
2373.T vs 9229.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 9229.T has a market cap of 8.1B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 9229.T trades at ¥249.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 9229.T's P/E ratio is -2.98. In terms of profitability, 2373.T's ROE is +0.12%, compared to 9229.T's ROE of -0.38%. Regarding short-term risk, 2373.T is less volatile compared to 9229.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 9229.T's competition here
2373.T vs 7133.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 7133.T has a market cap of 8B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 7133.T trades at ¥1,126.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 7133.T's P/E ratio is 14.66. In terms of profitability, 2373.T's ROE is +0.12%, compared to 7133.T's ROE of +0.24%. Regarding short-term risk, 2373.T is less volatile compared to 7133.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 7133.T's competition here
2373.T vs 6557.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 6557.T has a market cap of 7.7B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 6557.T trades at ¥1,195.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 6557.T's P/E ratio is 16.41. In terms of profitability, 2373.T's ROE is +0.12%, compared to 6557.T's ROE of +0.19%. Regarding short-term risk, 2373.T is less volatile compared to 6557.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 6557.T's competition here
2373.T vs 160A.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 160A.T has a market cap of 7.6B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 160A.T trades at ¥2,120.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 160A.T's P/E ratio is 6.72. In terms of profitability, 2373.T's ROE is +0.12%, compared to 160A.T's ROE of +0.25%. Regarding short-term risk, 2373.T is less volatile compared to 160A.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 160A.T's competition here
2373.T vs 8769.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 8769.T has a market cap of 7.3B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 8769.T trades at ¥463.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 8769.T's P/E ratio is 7.05. In terms of profitability, 2373.T's ROE is +0.12%, compared to 8769.T's ROE of +0.25%. Regarding short-term risk, 2373.T is less volatile compared to 8769.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 8769.T's competition here
2373.T vs 6059.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 6059.T has a market cap of 6.9B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 6059.T trades at ¥353.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 6059.T's P/E ratio is 3.20. In terms of profitability, 2373.T's ROE is +0.12%, compared to 6059.T's ROE of +0.15%. Regarding short-term risk, 2373.T is less volatile compared to 6059.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 6059.T's competition here
2373.T vs 7061.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 7061.T has a market cap of 6.5B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 7061.T trades at ¥776.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 7061.T's P/E ratio is 23.61. In terms of profitability, 2373.T's ROE is +0.12%, compared to 7061.T's ROE of +0.08%. Regarding short-term risk, 2373.T is less volatile compared to 7061.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 7061.T's competition here
2373.T vs 7091.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 7091.T has a market cap of 5.8B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 7091.T trades at ¥1,287.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 7091.T's P/E ratio is 13.05. In terms of profitability, 2373.T's ROE is +0.12%, compared to 7091.T's ROE of +0.22%. Regarding short-term risk, 2373.T is less volatile compared to 7091.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 7091.T's competition here
2373.T vs 4172.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 4172.T has a market cap of 5.2B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 4172.T trades at ¥2,315.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 4172.T's P/E ratio is 11.51. In terms of profitability, 2373.T's ROE is +0.12%, compared to 4172.T's ROE of +0.11%. Regarding short-term risk, 2373.T is less volatile compared to 4172.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 4172.T's competition here
2373.T vs 7037.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 7037.T has a market cap of 4.1B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 7037.T trades at ¥893.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 7037.T's P/E ratio is 37.10. In terms of profitability, 2373.T's ROE is +0.12%, compared to 7037.T's ROE of +0.06%. Regarding short-term risk, 2373.T is less volatile compared to 7037.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 7037.T's competition here
2373.T vs 7129.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 7129.T has a market cap of 3.2B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 7129.T trades at ¥1,141.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 7129.T's P/E ratio is 9.52. In terms of profitability, 2373.T's ROE is +0.12%, compared to 7129.T's ROE of +0.01%. Regarding short-term risk, 2373.T is less volatile compared to 7129.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 7129.T's competition here
2373.T vs 9220.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 9220.T has a market cap of 2.9B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 9220.T trades at ¥1,189.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 9220.T's P/E ratio is 6.64. In terms of profitability, 2373.T's ROE is +0.12%, compared to 9220.T's ROE of +0.13%. Regarding short-term risk, 2373.T is less volatile compared to 9220.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 9220.T's competition here
2373.T vs 2425.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 2425.T has a market cap of 2.8B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 2425.T trades at ¥751.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 2425.T's P/E ratio is 10.86. In terms of profitability, 2373.T's ROE is +0.12%, compared to 2425.T's ROE of +0.08%. Regarding short-term risk, 2373.T is more volatile compared to 2425.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2373.T.Check 2425.T's competition here
2373.T vs 2435.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 2435.T has a market cap of 2.5B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 2435.T trades at ¥220.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 2435.T's P/E ratio is 5.76. In terms of profitability, 2373.T's ROE is +0.12%, compared to 2435.T's ROE of +0.26%. Regarding short-term risk, 2373.T is less volatile compared to 2435.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 2435.T's competition here
2373.T vs 189A.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 189A.T has a market cap of 2.1B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 189A.T trades at ¥930.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 189A.T's P/E ratio is 9.81. In terms of profitability, 2373.T's ROE is +0.12%, compared to 189A.T's ROE of +0.10%. Regarding short-term risk, 2373.T is more volatile compared to 189A.T. This indicates potentially higher risk in terms of short-term price fluctuations for 2373.T.Check 189A.T's competition here
2373.T vs 9214.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 9214.T has a market cap of 1.9B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 9214.T trades at ¥1,406.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 9214.T's P/E ratio is 15.16. In terms of profitability, 2373.T's ROE is +0.12%, compared to 9214.T's ROE of +0.17%. Regarding short-term risk, 2373.T is less volatile compared to 9214.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 9214.T's competition here
2373.T vs 6029.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 6029.T has a market cap of 1.5B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 6029.T trades at ¥143.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 6029.T's P/E ratio is 5.68. In terms of profitability, 2373.T's ROE is +0.12%, compared to 6029.T's ROE of +0.16%. Regarding short-term risk, 2373.T is less volatile compared to 6029.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 6029.T's competition here
2373.T vs 7362.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 7362.T has a market cap of 1.2B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 7362.T trades at ¥803.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 7362.T's P/E ratio is 14.87. In terms of profitability, 2373.T's ROE is +0.12%, compared to 7362.T's ROE of +0.06%. Regarding short-term risk, 2373.T is less volatile compared to 7362.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 7362.T's competition here
2373.T vs 7363.T Comparison April 2026
2373.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 2373.T stands at 5.9B. In comparison, 7363.T has a market cap of 1.1B. Regarding current trading prices, 2373.T is priced at ¥437.00, while 7363.T trades at ¥1,285.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
2373.T currently has a P/E ratio of 15.35, whereas 7363.T's P/E ratio is 23.05. In terms of profitability, 2373.T's ROE is +0.12%, compared to 7363.T's ROE of +0.10%. Regarding short-term risk, 2373.T is less volatile compared to 7363.T. This indicates potentially lower risk in terms of short-term price fluctuations for 2373.T.Check 7363.T's competition here